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A b s t r a c t  
Back ground: Nano drug delivery systems  have rapid onset of action with enhanced therapeutic 
efficacy, decreased  dose of  the drug and decreased toxic effects when compared to conventional 
drug delivery systems. Hence neomycin is formulated into nanoparticles in order to increase the 
therapeutic efficacy, decrease the dose of drug and to decrease the topical dose related toxic 
effects. Aim: Hence the present work was aimed at the  preparation of  zinc nanoparticles (NP1), 
chitosan nanoparticles (NP2), different zinc chitosan neomycin nanoparticles 
(NP3,NP4,NP5,NP6,NP7,NP8) by altering the concentrations of chitosan and neomycin used in the 
formulation in order to optimise the composition.  Methods: Nanoparticles were prepared by  
subjecting the nanosuspension containing the specified ingredients to stirring at 40оC for 4-5 hr. 
The prepared nanoparticles were evaluated for particle size and surface morphology by 
Transmission Electron Microscopy (TEM), mean particle size and particle size distribution by zeta 
sizer, percentage yield, loading efficiency, in-vitro drug release by diffusion technique and agar cup 
plate method and invivo wound healing activity. Results: Among all the prepared zinc chitosan 
neomycin nanoparticles  NP6 was found to possess maximum in-vitro drug release and 
antimicrobial activity. This may be due to the synergistic effect of all the ingredients i.e zinc, chitosan 
and neomycin  present in the  formulation. Hence zinc chitosan neomycin nanoparticles NP6 was 
subjected to  in-vivo studies  and compared with marketed neomycin ointment (nemozin). The 
wound healing was found to be more in group treated with ointment prepared with zinc chitosan 
neomycin  nanoparticles compared to group treated with marketed neomycin ointment(nemozin) 
containing double the concentration of neomycin of NP6. Conclusion: Thus, the present work 
suggested that NP6 (0.2%) was found to be the best formulation of neomycin containing  less than 
half of the concentration of neomycin of nemozin ointment(0.5%) as it shown equal invivo activity to 
nemozin ointment as this reduces the side effects, increases efficacy at low doses of drug compared 
to conventional formulations of neomycin.  
Keywords: Chitosan, Zinc nano particles, Neomycin, Zinc chitosan neomycin, ointment, wound 
healing.
Introduction  
Nanoparticles can be defined as sub-micron sized colloidal 
particles composed of synthetic or semi-synthetic polymers having 
size range of 1 nm to 1000 nm. [1]. They contain macromolecular 
materials in which the active principle (drug / biologically active 
agent) is dissolved or entrapped or encapsulated to which the 
active principle is adsorbed or attached[2].  Nanoparticles can be 
easily up taken by the cells and can reach every cell to produce 
effective delivery when compared with conventional carrier [3,4]. 
These enable the drug to enhance the bioavailability, decrease the 
toxicity[5], decreases the frequency of administration.  Metallic 
nanoparticles can be defined as sub-nanosized colloidal particles 
produced from metals are called metallic nanoparticles.  
Advantages of metallic nanoparticles include high surface to 
volume ratio[6,7], uniform size distribution, better optical 
properties[8,9], better interaction with the biomolecules both at the 
surface and interior of the cell.   Zinc oxide nanoparticles have anti-
bacterial, anti-fungal and growth promoting activity[10,11]. 
Chitosan is used as a polymer because it exhibits antimicrobial 
activity against bacteria[12], fungi  and yeast , biocompatible[13], 
non-toxic, biodegradable[14,15], used as wound healing 
accelerator[16,17] as it enhances the function of 
polymorphonuclear cells, macrophages and enhances fibroblastic 
proliferation of migration[18]. These properties render chitosan a 
very attractive material as a drug delivery carrier.  
Nanoparticles have a relatively large (functional) surface which is 
able to bind, adsorb and carry other compounds such as drugs, 
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probes and proteins. Because of their ability to carry the drugs 
and proteins, zinc chitosan neomycin nanoparticles were 
formulated to enhance the  therapeutic efficacy of neomycin to 
decrease the dose related  toxic effects of neomycin ointment such 
as hypersensitivity reactions, rashes and burning sensation by 
decreasing the dose of the drug and enhancing its absorption. Zinc 
and chitosan were used because of their antibacterial activity[19].  
Different zinc, chitosan, neomycin nanoparticles were evaluated 
and compared with the marketed neomycin ointment  to optimize 
the composition of chitosan and neomycin in formulation.  
Materials and Methods 
Materials 
Neomycin (Gift sample from Natco pharma pvt limited, Hyderabad), 
chitosan (Sigma Aldrich, Hyderabad), nanozinc oxide (Yogi dye 
chem pvt limited), acetic acid (Sd fine, Mumbai), agar, beef extract, 
sodium chloride (Himedia pvt.limited, Mumbai), methanol (Himedia 
pvt.limited, Mumbai), PEG 400 and PEG 4000 (Himedia pvt.limited, 
Mumbai)  Bacillus subtilis, Staphylococcus aureus & two gram 
negative  bacteria Escherichia coli, Pseudomonas aeruginosa  
obtained from NCL , Pune.  All the chemicals and reagents used 
were of analytical and pharmaceutical grade. 
Methods 
Method of preparation of Nanoparticles 
2% neomycin, 2% chitosan and 0.2% nano zinc oxide solutions 
were prepared. 50ml of zinc oxide solution was added to 40 ml 
each of neomycin and chitosan solutions. The above solution was 
stirred continuously using magnetic stirrer by heating at 40оC for 4-
5 hr.. The nanosuspension i.e formed was centrifuged. The 
sediment was dried and the dried nanoparticles  were  evaluated. 
Different nanoparticles as shown in table 1 were prepared  by 
following the same procedure. 
 
Table 1:Composition of various nanoparticles 
Sl.No
. 
Code of the 
formulation 
Neomycin 
% 
Chitosan 
% 
Nano zinc 
oxide % 
1. NP1 - - 0.2 %
2. NP2 - 2 % -
3. NP3 2 % 2 % 0.2 %
4. NP4 2 % 4 % 0.2 %
5. NP5 2 % 6 % 0.2 %
6. NP6 4 % 2 % 0.2 %
7. NP7 4 % 4 % 0.2 %
8. NP8 4 % 6 % 0.2 %
 
 
Characterization of nanoparticles [20,21]  
 Surface morphology 
 TEM analysis 
The morphological characteristics of nanoparticles were 
determined by  Transmission electronic microscopic (TEM)   
TEM1200EXJEOL, Japan.  Specified quantity of the best of the 
nanoparticles  were placed on the carbon coated copper grid 
making a thin film of sample on the grid and extra sample was 
removed using the cone of a blotting paper & kept in grid box 
sequentially. Then TEM microphotographs of best formulation of 
nanoparticles   (NP6) were taken [17]. 
 Particle size analysis 
The mean particle size and particle size distribution of the drug 
loaded nanoparticles (NP6) and zeta potential was measured using 
zeta sizer (nanoparticle SZ 100, Horiba Singapore) by determining 
the electrophoretic mobility in a microelectrophoresis flow cell at 
25о C.  
Compatibility studies  
The compatibility  between drug , polymer and metal was  
determined by carrying out UV scan using UV- Vis 
spectrophotometer (schimadzu). The possible interaction between 
neomycin, chitosan and zinc was also accessed by comparing 
FTIR spectra of pure drug (neomycin), polymer (chitosan) and 
nanoparticle formulation. 
Percentage Yield [22] 
The formulation is centrifuged and sediments were dried. 
Percentage yield was calculated as follows: 
                                      % Yield =  Nanoparticles weight  X 100 
            Total solids weight 
Total solids weight = weight of nano zinc oxide + weight of 
neomycin + weight of chitosan 
 Loading efficiency 
 Nanosuspension with known amount of drug was centrifuged at 
5000 rpm for 15 min. The supernatant solution was separated. 5 ml 
of supernatant was distributed with 100 ml of distilled  water. 
Absorbance was measured using UV Spectrophotometer using 
distilled water as blank. The amount of drug entrapped in the 
supernatant was calculated from which the amount of drug 
entrapped and % entrapment was determined. 
Loading efficiency =Total amount of drugăAmount of unbound drug    
                                                              Weight of Nanoparticles    
 In vitro drug release studies  
In vitro drug release by diffusion studies[21]  
The in vitro drug diffusion of all the drug loaded formulations were 
carried using dialysis membrane. 5 ml of formulation was 
accurately placed in this assembly. The cylinder was attached to 
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the stand and suspended in 50 ml of dissolution medium 
maintained at 37μ 5оC so that the membrane just touched the 
receptor medium surface. The dissolution medium was stirred at 
lower speed using magnetic stirrer. Aliquots of samples were 
withdrawn at regular intervals and replaced with equal volume. The 
samples were analyzed by UV-Visible Spectrophotometer  and 
cumulative percentage release of all formulations were specified in 
the tabular form. The quantity of drug equivalent to 10 mg was 
taken for diffusion study. 
 In vitro antibacterial activity  by agar cup plate method 
The prepared nanoparticles were evaluated for antibacterial activity 
against four different strains with agar cup plate method by 
measuring the zone of inhibition of microorganisms.  Zone of 
inhibition was determined for all the prepared formulations. 
separately by incubating for 24 hr at 37 μ 2оC. Zone of inhibition 
was determined in triplicate using antibiotic zone reader and 
average diameter was noted. 
 In vivo Studies 
The best among the prepared zinc chitosan neomycin 
nanoparticles  (NP6) possessing highest in-vitro antimicrobial 
activity and blank nanoparticles (NP1 and NP2) were prepared into 
an ointment  for in vivo study of wound healing activity on albino 
rats by excision wound model. Pathogen free adult albino rats 
weighing 150-200 gm. were selected.    The wound healing activity 
was conducted with the protocol as shown in the table 2 with each 
group containing 6 animals. The animal work was approved by 
institutional ethical committee.         
 
             Table 2 : Protocol for in vivo wound healing studies 
Sl. No Group 
number 
Purpose 
1. Group 1  Control (Untreated) 
2. Group 2 Treated with zinc nanoparticles (NP1).      
(Blank 1) 
3. Group 3 Treated with chitosan nanoparticles 
(NP2) (Blank 2) 
4. Group 4 Treated with zinc chitosan neomycin   
nanoparticles (NP6) 
5. Group 5 Treated with the marketed neomycin 
ointment (nemozin). 
 
Wound with an area of 2 cm2 was created  on the back of the 
anaesthetized animals on interscapular region that is 5mm away 
from the ears.   After achieving homeostasis, the wound was 
blotted with sterile gauze in control group, the respective ointment 
was placed on the wound of animals in treatment groups.  Then the 
following parameters were determined at specific time intervals: 
Percentage of wound contraction [23,24,25] 
 This is measured to determine the reduction of wound area at 
different periods  of treatment.  It was measured by graphical 
method. Wound area was calculated on 7th, 9th, 11th, 13th, 15th  
post wounding day by counting the number of squares of retraced 
wound area on graph paper. The degree of wound healing was 
calculated as % closure of the wound area from the original wound 
using the formula: % Closure = 1-[Ad/Aо] X 100.         Ao    is the 
wound area on day zero,  Ad  is the wound area on corresponding 
days. 
 Photography 
The photographs of wounds from different groups were taken at 
regular intervals for visual comparison. 
Biochemical analysis[26] 
After seventh, ninth and fourteenth day of wound creation on 
animals, the healed skin was carefully lifted, freed of adhesions 
and  excised along with 2 mm adjacent to normal skin. The 
granulation tissue was subjected for estimation of biochemical 
parameters. 
Estimation of Hydroxyproline content  
Collagen is the major extracellular protein in the granular tissue of 
the healing wound and there is rapid increase in the synthesis of 
the collagen in the wound area soon after an injury, which provides 
strength and integrity to tissue matrix. Measurement of 
hydroxyproline which comes from breakdown of collagen has been 
used as an index of collagen turn over. Increase in hydroxyproline 
content of the granular  content in the wound is an indication of 
higher collagen content and its turnover leading to rapid healing. 
Procedure 
 The stored tissue was dried in an oven at 60о Că70оC for 12ă18 h, 
and the dry weight was noted. The tissues were hydrolyzed in 6 N 
HCl for 24 hr at 110 оC in sealed glass tubes. The hydrolysate was 
neutralized to pH 7.0. The sample (200 μl) was mixed with 1mL of 
0.01M CuSO4 , 1ml of 2.5N NaOH and 1mL of 6% H2O2. All the 
tubes were incubated at 80оC for 5 min with frequent vigorous 
shaking. Upon cooling, 4mL of 3N H2SO4 was added with agitation. 
Finally, 2 ml of 5% para-dimethylaminobenzaldehyde was added to 
develop a pink color. The samples were incubated at 70◦C for 16 
min, cooled by placing the tubes in water at 20о C and the 
absorbance was measured at 540 nm using a spectrophotometer. 
The amount of hydroxyproline in the samples was calculated using 
a standard solution and its corresponding absorbance at the same 
time[36] by following formula:  
Concentration of hydroxyl proline=OD of the Sample x  
Concentration of standard 
               in the sample                         OD of Standard   
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Estimation of  hexosamine content  
Hexosamine and hexuronic acid are matrix molecules, which act as 
ground substratum for the synthesis of new extracellular matrix. 
These substances form a highly hydrated gel like ground 
substance, a provisional matrix upon which collagen substances 
are embedded. Hexosamine concentration increases with wound 
healing, ultimately increases the tensile strength. 
Procedure 
Granulation tissue weighing around 300mg was homogenized in 10 
ml of 6N HCl in 25 ml glass ampoules and were  hydrolyzed at 98о 
C. After hydrolysis, washed thoroughly with water and the 
washings were combined with the hydrolysate. The pH of the 
hydrolysate was adjusted to 7,  sample was diluted to 50 ml with 
distilled water. To 2 ml of above sample, 1 ml of 2% acetylacetone 
was added and heated to 96оC for 40 minutes. The mixture was 
cooled and 5 ml of 96% ethanol was added followed by the 
addition of 1 ml of ehrlichÊs reagent (320 mg of p-dimethyl amino 
benzaldehyde was dissolved in 21 ml of iso-propranol and 4 ml of 
con.HCl was added). The solution was thoroughly mixed and kept 
at room temperature for 1 hr. The absorbance of the pink colour 
solution was measured at 530 nm. The amount of hexosamine was 
determined by comparing with the standard value by following 
formula: 
Concentration of the sample = OD of the sample x  Concentration 
of standard 
                                                                OD of the standard   
 
   The results of in-vivo studies were compared with the results of 
marketed neomycin ointment (nemozin). 
Statistical analysis 
The results are expressed as Mean μ S.D by estimating all the 
above in-vitro, in-vivo parameters in triplicate. Then  statistical 
analysis was performed by  t-test, one way analysis of variance 
(ANOVA) for multiple comparisons using SPSS statistics software 
17.0 version. Statistical significance was set accordingly at P 
(<0.05) level. 
Results and Discussion       
 In the present study, zinc nanoparticles (NP1), chitosan 
nanoparticles (NP2) and zinc chitosan neomycin nanoparticles 
(NP3) were prepared by altering the concentrations of chitosan and 
neomycin and characterized to find out the effect of neomycin and 
chitosan on antibacterial activity of zinc neomycin nanoparticles. 
These zinc chitosan neomycin nanoparticles were formulated to 
get  maximum loading efficiency, invitro drug release by diffusion 
studies and agar cup plate method and the best of the prepared 
nanoparticles were subjected to invivo studies using albino rats by 
excision wound model and compared with the marketed neomycin 
ointment (nemozin) along with blank nanoparticles. 
 Particle size and surface morphology  
 TEM analysis 
Particle size  and surface morphology of the best formulation i.e 
zinc  neomycin nanoparticles (NP6) was determined by 
Transmission Electron Microscopy and its TEM microphotographs 
are shown in  figure 1. The particle size of zinc chitosan neomycin 
nanoparticles(NP6) was found to be 200 nm. and are are  spherical 
in shape with smooth surface and are in nanometric size. 
 
 
                 
Figure 1:TEM microphotographs of zinc chitosan neomycin nanoparticles(NP6).  
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 Zeta sizer 
Mean particle size and particle size distribution of the best of the 
prepared nanoparticles zinc chitosan neomycin nanoparticles 
(NP6) was determined using zeta sizer. The mean particle size of 
NP6 was found to be 111.5 nm as given in figure 2.  It indicated 
that the narrow size distribution or more uniform size distribution 
was found with zinc chitosan neomycin nanoparticles (NP6). 
 
 
  Figure 2: Particle size determination of zinc chitosan neomycin nanoparticles (NP6) 
Compatibility studies 
The compatibility of neomycin with  chitosan and zinc in zinc 
chitosan neomycin nanoparticles was determined through UV 
scan, FTIR analysis. The UV spectrum of pure drug solution and 
zinc chitosan neomycin nanoparticle formulation were identical and 
the characteristic absorption maxima was appeared at 273 nm.  
The  FTIR spectra of pure neomycin, pure chitosan, zinc chitosan 
neomycin nanoparticles (NP6) were obtained.  FTIR spectrum of 
pure neomycin demonstrated  the characteristic absorption peaks 
at 3240 cm-1   for O-H stretching conjugated with N-H stretching 
and aromatic C-H stretching, at  1341 cm-1  for C-N stretching, at 
1075 cm-1  for C-O stretching, at 1530 cm-1  for ăC-C- stretching. 
The absorption peaks with zinc chitosan neomycin nanoparticles 
were almost similar to those obtained with the pure drug and 
polymer. 
Percentage yield and Loading effieciency 
The % yield of  nanoparticles varied from 72.45 μ 0.12 to 83.04 μ 
0.31 as given in table 3. Among all the prepared nanoparticles the  
% yield was found to be less for zinc nanoparticles (NP1) i.e 
72.45%  and  highest for zinc chitosan neomycin nanoparticles 
(NP8) i.e  83.04%. The percentage yield was found to be increased 
with increased concentration of drug and polymer.   
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The loading efficiency of  different nanoparticles varied  from 
75.92% to 85.44% as shown in table 3. Among all the zinc chitosan 
neomycin nanoparticles formulated, NP8 was found to exhibit 
maximum loading efficiency i.e 85.44% which may be due to higher 
concentration of drug and polymer used in the formulation and the 
ability of the polymer to form reticulated sheath which ultimately 
enhances the drug loading. Loading efficiency was found to be 
increased with increased concentration of polymer and drug.  
 
Table 3: Percentage yield and loading efficiency of various  
     nanoparticles 
Sl. No. Formulation 
code 
%  Yield 
(Mean μ S.D) 
Loading 
efficiency 
(Mean μ S.D) 
1. NP1 72.45 μ 0.12 _
2. NP2 74.94 μ 0.13 _
3. NP3 75.13 μ 0.26 75.92 μ 0.23
4. NP4 80.49 μ 0.28 83.21 μ 0.24
5. NP5 81.13 μ 0.19 84.12 μ 0.11
6. NP6 79.46 μ 0.34 81.23 μ 0.29
7. NP7 81.67 μ 0.26 84.35 μ  0.25
8. NP8 83.04 μ 0.31 85.44 μ 0.26
 Invitro drug release 
 By diffusion studies 
The in-vitro % drug release by diffusion studies was determined for 
all the nanoparticles for 2 hrs. At the end of 2 hrs the in-vitro % 
drug release of different nanoparticles was found to be between 
74.67 to 83.36 % as shown in table 4 The  in-vitro % drug release 
from  zinc chitosan neomycin nanoparticles (NP3) was found to be 
79.56 %. Among all the formulations, NP6 was found to possess 
highest in-vitro % drug release i.e 83.36%. The  in-vitro %  drug 
release was not significantly (P<0.05) changed with increase in 
concentration of polymer as shown in table 4. But the  in-vitro %   
drug release was significantly increased with increase in 
concentration of drug (P<0.05). It may be due to the presence of 
more drug and it may also allow to assume the release by diffusion 
process following first order kinetics as release was increased with 
increase in concentration of drug which can be supported by the 
reports of mohammad.F et al.,2010[27] conducted up on chitosan 
ampicillin. 
 
Table 4: In-vitro % drug release of different zinc chitosan neomycin nanoparticles with different concentrations of polymer and drug 
 2% Neomycin formulations 4% Neomycin formulations 
Time 
(min) 
NP3 
(Mean μS.D) 
NP4 
(Mean μS.D) 
NP5
(Mean μS.D) 
NP6
(Mean μS.D) 
NP7 
(Mean μS.D) 
NP8
(Mean μS.D) 
15 73.62μ0.11 72.21 μ0.32 72.05μ0.41 76.96μ0.23 76.51μ0.43 76.11μ0.15
30 73.91μ0.13 74.03μ0.24 72.86μ0.38 78.01μ0.16 78.04μ0.21 77.79μ0.34
45 75.23μ0.24 74.98μ0.49 74.01μ0.16 78.96μ0.33 78.80μ0.33 77.95μ0.51
60 75.50μ0.43 75.45μ0.27 75.10μ0.55 79.03μ0.46 78.98μ0.54 78.05μ0.39
75 76.21μ0.36 76.07μ0.18 75.96μ0.44 80.91μ0.55 79.90μ0.19 78.89μ0.11
90 77.52μ0.26 77.11μ0.25 76.65μ0.37 82.03μ0.49 80.18μ0.21 79.95μ0.23
105 77.83μ0.19 77.91μ0.19 77.79μ0.29 82.98μ0.33 81.15μ0.43 80.02μ0.14
120 79.56μ0.32 79.23μ0.34 79.05μ0.36 83.36μ0.42 81.19μ0.34 80.45μ0.25
 
 Antibacterial activity by agar  cup plate technique 
The antibacterial activity of different nanoparticles was determined 
and shown in figure 3&4. The antibacterial activity of drug loaded 
nanoparticles was significantly more than blank nanoparticles 
against all selected species(P<0.05).  
Among the prepared nanoparticles, zinc nanoparticles (NP1) was 
found to have the least antibacterial activity and zinc chitosan 
neomycin nanoparticles (NP6) was found to possesses highest 
antibacterial activity. It may be due to the synergistic effect of all 
the ingredients i.e zinc, chitosan, neomycin present in the 
formulation (NP6)[28] and also due to increased surface area with 
decrease in particle size. Increase in antibacterial effect was found 
by increased drug loading, when compared with NP1 and NP2. 
However blank chitosan nanoparticles (NP2) have shown higher in-
vitro antibacterial activity than blank zinc nanoparticles (NP1), 
indicated more capacity of chitosan to act against different strains 
of bacteria[13]. NP6 was found to possesss highest anti-bacterial 
activity when compared to other formulations and decreased in-
vitro release was found with further increase in polymer 
concentration which may be due to retarding effect of higher 
concentration of polymer (NP7 and NP8). Hence it was formulated 
into ointment and subjected to in-vivo wound healing activity by 
excision wound model and compared with the marketed neomycin 
ointment (nemozin). 
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      Figure 3: Zone of inhibition of NP1, NP2, NP3 (blank NP) 
 
 
 
Figure 4: Zone of inhibition of different zinc chitosan neomycin nanoparticles 
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 In-vivo studies 
 Percentage wound contraction 
The in-vivo studies were conducted for ointments prepared with 
best zinc chitosan neomycin nanoparticles (NP6), blank 
nanoparticles i.e pure zinc (NP1) and pure chitosan nanoparticles 
(NP2) and marketed neomycin ointment (nemozin). The 
percentage wound contraction was measured at 7th, 9th, 11th, 13th, 
15th post wounding days to estimate the reduction in wound  and 
results are  shown in table 5.  70.53% of wound was contracted in 
group 4 treated with NP6, whereas 69.8% wound contraction was 
observed with marketed neomycin ointment (nemozin) within a 
week. The contraction of wound at the end of 15th day for group 4 
treated with NP6 and neomycin ointment (nemozin) was found to 
be  99.63, 98.67 respectively. This indicated that almost complete  
wound was healed by 15 days when compared to group 2 and 3 
treated with blank zinc nanoparticles (NP1) and chitosan 
nanoparticles (NP2). 
The % wound contraction was significantly increased with metallic 
nanobiocomposite of neomycin i.e zinc chitosan neomycin 
nanoparticles (NP6) when compared to zinc nanoparticles (NP1) 
and chitosan nanoparticles (NP2) (P<0.05)  as per the table 5. It 
was found that the % wound contraction of chitosan nanoparticles 
(NP2) was found to be more than zinc nanoparticles (NP1), which 
may be due to higher antimicrobial activity of chitosan or may be 
due to augmentation of restoration of skin cells in wounded 
area[16]. It may also be due to the ability of chitosan to enhance 
the fibroblast proliferation , increased function of 
polymorphonuclear cells, macrophages, that lead to formation of 
new extracellular matrix by excreting collagen, which ultimately 
leads to wound contraction[18]. The highest % wound contraction 
was found with NP6 i.e zinc chitosan neomycin nanoparticles 
which may be due to synergistic antimicrobial effect of zinc, 
chitosan, neomycin[28] or due to increased surface area with 
decreased particle size upon incorporation of polymer. Despite of 
the less concentration of neomycin used in formulation of the 
ointment from NP6 i.e 0.2% , the prepared ointment has better 
wound healing activity than the marketed formulation containing 
0.5% neomycin which indicated that the NP6 is the best 
formulation.  
 
Table 5. Percentage wound contraction 
Time 
(days) 
Group 1 
(Untreated) 
(Mean μ S.D) 
Group 2
(NP1) 
(Mean μ S.D) 
Group 3
(NP2) 
(Mean μ S.D) 
Group 4 
(NP7) 
(Mean μ S.D) 
Group 5
(nemozin) 
(Mean μ S.D) 
7 29.97 μ 0.29 36.64 μ 0.47 41.96 μ 0.55 70.53 μ 0.57 69.8 μ 0.36
9 42.98 μ 0.37 45.57 μ 0.39 48.87 μ 0.47 77.76 μ 0.75 78.23 μ 0.34
11 57.78 μ 0.51 55.55 μ 0.39 59.75 μ 0.46 85.89 μ 0.45 85.86 μ 0.27
13 62.23 μ 0.32 68.56 μ 0.47 76.66 μ 0.36 96.39 μ 0.49 95.94 μ 0.66
15 76.76 μ 0.43 81.87 μ 0.49 84.87 μ 0.39 99.63 μ 0.46 98.69 μ 0.43
 
Photography  
Based on the photography, the wound size was decreased in all 
groups by 15 days when compared to 0th day as shown in figure 5.  
Wound was recovered into normal skin in group 4 and 5 by 15th 
day. Among group 2 and 3, wound healing was found to be more in 
group 3, which indicated that chitosan nanoparticles (NP3) has 
more wound healing activity than zinc nanoparticles (NP2). The 
decrease in wound size was found to be more in group 4 treated 
with zinc chitosan neomycin ointment  when compared to other 
groups on respective days, this indicated that loading of drug into 
the blank nanoparticles augmented restoration of skin cells. This 
may be due to broad anti-bacterial activity of neomycin which 
reduces infections and  fastens wound healing or it may be due to 
the synergistic effect of all 3 components i.e zinc, chitosan, 
neomycin and increased surface area with decreased particle size. 
 
 
 Group 1 
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Group 2 
 
Group 3 
 
Group 4 
 
Group 5 
 
Figure 5: Comparison of photographs of wounds on 15th day in different groups  
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Biochemical analysis 
Wound healing was also determined based upon the 
hydroxyproline and hexosamine levels in healed skin. 
Hydroxyproline was found to be increased with rapid increase in 
wound healing. Among all,  the group 4  was found to have more 
hydroxyproline content, which indicated more wound healing 
activity as shown in table 6.  Hexosamine levels were found to be 
highest in group 4, indicated NP6 is more effective formulation than 
other prepared formulations and even the marketed neomycin 
ointment, though the percentage of neomycin used in NP6 (0.2%) 
is less than the marketed formulation (0.5%). This indicates that 
NP6 is the best formulation for wound healing activity with less 
than half of the concentration of drug in marketed preparation 
(nemozin 0.5%).  
           
Table 6: Hydroxy proline and Hexosamine content in different groups   
Group name Hydroxy proline content(mg/gm tissue) Hexosamine content(mg/gm tissue)
7th day 
(Mean μ S.D) 
10th day
(Mean μ S.D) 
14th  day
(Mean μ S.D) 
7th day
(Mean μ S.D) 
10th day 
(Mean μ S.D) 
14th  day
(Mean μ S.D) 
Group 1 10.23μ0.11 15.54μ0.33 20.54μ0.19 12.56μ0.24 15.89μ0.07 26.54μ0.05
Group 2 16.65μ0.25 18.89μ0.18 25.76μ0.14 14.35μ0.15 18.52μ0.36 29.76μ0.14
Group 3 17.78μ0.17 20.27μ0.19 28.34μ0.19 18.64μ0.19 26.39μ0.17 34.79μ0.13
Group 4 35.73μ0.29 51.36μ0.22 62.23μ0.21 28.45μ0.37 39.93μ0.13 57.75μ0.22
Group 5 35.11μ0.34 49.38μ0.16 60.48μ0.25 22.63μ0.11 31.37μ0.21 54.86μ028
 
Conclusion 
Of the first three (NP1,NP2,NP3) nanoparticles, zinc chitosan 
neomycin nanoparticles (NP3) was found to possess maximum 
percentage yield, loading efficiency, in-vitro drug release and in-
vitro antimicrobial activity. Hence zinc chitosan neomycin 
nanoparticles were subjected to optimization by altering the 
concentration of chitosan and neomycin used in the formulation. 
Among all the prepared zinc chitosan neomycin nanoparticles 
(NP4,NP5,NP6,NP7,NP8) NP6 was found to possess maximum in-
vitro drug release and in-vitro antimicrobial activity. This may be 
due to the synergistic effect of all the ingredients i.e zinc, chitosan 
and neomycin  present in the  formulation. Hence zinc chitosan 
neomycin nanoparticles NP6 was subjected to  in-vivo studies  and 
compared with the zinc nanoparticles (NP1), chitosan 
nanoparticles (NP2) by formulating into ointment  and marketed 
neomycin ointment (nemozin). The % wound contraction, 
hexosamine and hydroxyproline content was found to be more in  
 
 
 
group 4 treated by ointment prepared with zinc chitosan neomycin 
nanoparticles (NP6). This indicates that wound healing was found 
to be more in group 4 treated with ointment prepared with zinc 
chitosan neomycin  nanoparticles compared to group 5 treated with 
marketed neomycin ointment(nemozin) containing double the 
concentration of neomycin of NP6. 
Thus the prepared zinc chitosan neomycin nanoparticles (NP6) can 
be considered as the best formulation of neomycin with less than 
half of the concentration of neomycin of nemozin ointment, as this 
reduces the side effects like hypersensitive reactions, rashes, 
itching, burning sensation caused by the use of conventional 
neomycin preparations (like ointments, creams, gels etc) with 
increased efficacy at low doses of drug.   
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